Alerts will be sent to your verified email
Verify Email
APPL
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Aptus Pharma is engaged in the business of marketing, and distribution of finished pharmaceutical formulations. It operates through a contract manufacturing model. It provides a diverse range of pharmaceutical products catering to various therapeutic categories including anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, etc.
Aptus Pharma major competitors are Zota Health Care, Sunrest Lifescience, Lincoln Pharma.
Market Cap of Aptus Pharma is ₹110 Crs.
While the median market cap of its peers are ₹1,012 Crs.
Aptus Pharma seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | ||||||||||||||||||
| Investor Presentation | ||||||||||||||||||
| Conference Call | ||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
